Vaxart, Inc. (VXRT) Return on equity 2016–2025
Vaxart, Inc. (VXRT) return on equity by fiscal year — reported net income divided by year-end shareholders’ equity.
18.6%FY2025 · since FY2016: -157.2% → 18.6%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | 18.6% | +132.2 pp |
| FY2024 | -113.6% | +29.0 pp |
| FY2023 | -142.7% | -45.2 pp |
| FY2022 | -97.4% | -59.9 pp |
| FY2021 | -37.6% | -11.5 pp |
| FY2020 | -26.1% | +117.8 pp |
| FY2019 | -144.0% | +16.7 pp |
| FY2018 | -160.6% | — |
| FY2016 | -157.2% | — |
ROE = reported net income ÷ reported year-end shareholders’ equity for the same fiscal year. Heavy buybacks shrink equity and can push ROE very high (or negative-equity years drop out).
Source: SEC XBRL filings · For reference only · Not investment advice
More VXRT financial trends
VXRT RevenueVXRT Net incomeVXRT Net marginVXRT Gross profitVXRT Gross marginVXRT Operating incomeVXRT Operating marginVXRT Operating cash flowVXRT Free cash flowVXRT Capital expendituresVXRT Stock buybacksVXRT Dividends paidVXRT Total assetsVXRT Total liabilitiesVXRT Shareholders’ equityVXRT overview →